Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,646 public trials 848 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Recruiting

A Study of XS-04 in Patients with Relapsed or Refractory Hematologic Malignancies

NCT06820268

Conditions: Acute Myeloid Leukemia, B-cell Lymphoma, Bone Marrow Diseases, +16 more
Locations: Beijing Cancer Hospital Beijing, China

Sun Yat-sen University Cancer Center Guangdong, China

Affiliated Hospital of Hebei University Hebei, China

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Hubei, China

View Trial Details

Recruiting

A Phase III Clinical Study Comparing JS004 Plus Toripalimab With Investigator-Selected Chemotherapy in Patients With PD-(L)1monoclonal Antibody Refractory Classic Hodgkin Lymphoma (cHL)

NCT06170489

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

PTCy and ATG for MSD and MUD Transplants

NCT06299462

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +20 more
Locations: Instituto Nacional de Cancer Rio de Janeiro, Brazil

View Trial Details

Recruiting

A Study of Patients With Relapsed/Refractory Mantle Cell Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting

NCT06788652

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Center for International Blood and Marrow Transplant Research (CIBMTR) Milwaukee, Wisconsin, United States

View Trial Details

Recruiting

A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting

NCT06794268

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: CIBMTR Milwaukee, Wisconsin, United States

View Trial Details

Recruiting

A Prospective, Randomized Clinical Study of Two Phakic Toric Implantable Lenses

NCT06839898

Conditions: Astigmatism, Eye Diseases, Hemic and Lymphatic Diseases, +14 more
Locations: Precise Vision Augentagesklinik Greven Münster, North Rhine-Westphalia, Germany

Precise Vision Augentagesklinik Rheine Rheine, North Rhine-Westphalia, Germany

Precise Vision Augentagesklinik Rheine Steinfurt, North Rhine-Westphalia, Germany

Netradhama Superspeciality Eye Hospital Bangalore, Karnataka, India

View Trial Details

Recruiting

Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL

NCT06151080

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Follicular Lymphoma, +12 more
Locations: Bing Xu Xiamen, Fujian, China

View Trial Details

Recruiting

Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular Lymphoma

NCT06158386

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Bing Xu Xiamen, Fujian, China

View Trial Details

Recruiting

Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma

NCT06151106

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations: The First Affiliated Hosptial of Xiamen University Xiamen, Fujian, China

View Trial Details

Recruiting

Study of Pomalidomide Combination with Rituximab and Anti-PD-1 Antibody （PPR） in Third or Later Line Therapy of DLBCL

NCT06832228

Conditions: Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Zhejiang Cancer Hospital Hangzhou, Zhejiang, China

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions